Summaries by Inventor Weber, Jason

Tumor treatment for patients with neurofibromatosis type 1 (NF1)
Gutmann, David ; Weber, Jason
T-007548

— Technology Description Scientists at the Washington University Neurofibromatosis Center have developed a patented, first-in-class method for treating neurofibromatosis type 1 (NF1) with small molecule inhibitors of targets in the mTOR (mammalian target of rapamycin) signaling pathway. NF1 is a rel…

 

Create a Collection
Creating...